Cheryl Mongera
Nurse Practitioner · Corry, PANPI 1942288238
Payments from drug & device makers
Across 132 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$481
- Lilly USA, LLC$286
- Novo Nordisk$247
- Pfizer$223
- AbbVie$177
- GSK$151
- plus $703 from 13 others
What the payments were for
- Food & beverage$2,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $481 |
| Lilly USA, LLC | 17 | $286 |
| Novo Nordisk | 17 | $247 |
| Pfizer | 13 | $223 |
| AbbVie | 10 | $177 |
| GSK | 12 | $151 |
| Amgen | 6 | $114 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $94 |
| AstraZeneca | 5 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $69 |
| Merck | 4 | $64 |
| Boehringer Ingelheim | 4 | $55 |
| E.r. Squibb & Sons, L.L.C. | 4 | $52 |
| Astellas Pharma US Inc | 2 | $52 |
| Bayer | 3 | $45 |
| Exact Sciences | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Abbott | 1 | $14 |
How this compares
$2,268 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $45,334 |
| JanuviaSitagliptin Phosphate | 32 | $26,945 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $13,434 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $7,869 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,966 |
| Rosuvastatin Calcium | 72 | $1,355 |
| Potassium Chloride | 28 | $1,292 |
| Pantoprazole Sodium | 79 | $1,148 |
| Metoprolol Succinate | 69 | $1,143 |
| Gabapentin | 31 | $973 |
| Losartan Potassium | 92 | $962 |
| Atorvastatin Calcium | 144 | $929 |
| Montelukast Sodium | 67 | $897 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $743 |
| Ezetimibe | 22 | $685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $223 | $45,33438 claims |
| MerckJanuvia | $64 | $26,94532 claims |
| GSKTrelegy Ellipta | $151 | $13,43413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Corry
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.